New hope for kids with arthritis: experimental pill enters final testing
Disease control
Not yet recruiting
This study tests an oral drug called filgotinib in 65 children and teens (ages 8 to 17) with a type of arthritis that affects multiple joints. The goal is to see if the drug is safe and helps control joint inflammation and pain over 18 weeks. Participants will take the medication…
Phase: PHASE3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC